Scientific news publication Clinical Trials Arena reported that the Texas Heart Institute and medical device company BiVACOR successfully implanted a titanium heart. The artificial blood pump uses magnet technology akin to trains to circulate blood. The trial was part of the US Food and Drug Administration’s Early Feasibility Study for those waiting for heart transplants.